Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors

Clinical trial NCT00301756 · COMPLETED

Trial details

NCT number: NCT00301756
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fallopian Tube Carcinoma Primary Peritoneal Carcinoma Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor Recurrent Ovarian Carcinoma Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor Stage III Ovarian Cancer Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor Stage IV Ovarian Cancer

Start date: 2006-09-01
Primary completion: 2009-08-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.